Similar articles

• [Indium-111 antimyosin monoclonal antibody uptake in patients with cardiomyopathy and myocarditis].

  Matsumori A, Yamada T, Morishima S, Tamaki N, Watanabe Y, Yonekura Y, Endo K, Konishi J, Yoshida A, Kawai C. Matsumori A, et al. Kaku Igaku. 1990 Oct;27(10):1129-34. Kaku Igaku. 1990. PMID: 2277453 Japanese.
• Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging.

  Yamada T, Matsumori A, Tamaki N, Morishima S, Watanabe Y, Yonekura Y, Endo K, Konishi J, Kawai C. Yamada T, et al. Jpn Circ J. 1991 Apr;55(4):377-83. doi: 10.1253/jcj.55.377. Jpn Circ J. 1991. PMID: 2046143
• Monoclonal Fab antimyosin in cardiac imaging.

  Johnson LL. Johnson LL. Clin Cardiol. 1992 Mar;15(3):145-53. doi: 10.1002/clc.4960150304. Clin Cardiol. 1992. PMID: 1551261 Review.
• Clinical applications of antimyosin monoclonal antibody imaging.

  Maddahi J. Maddahi J. Am J Card Imaging. 1994 Jul;8(3):249-60. Am J Card Imaging. 1994. PMID: 7950176 Review. No abstract available.
• Indium-111 antimyosin antibody imaging and thallium-201 imaging--a comparative myocardial scintigraphic study using single-photon emission computed tomography in patients with myocarditis and dilated cardiomyopathy.

  Yamada T, Matsumori A, Tamaki N, Nohara R, Konishi J, Sasayama S. Yamada T, et al. Jpn Circ J. 1997 Oct;61(10):827-35. doi: 10.1253/jcj.61.827. Jpn Circ J. 1997. PMID: 9387064